The Global Pediatric Neurology Devices Market Size is projected to grow at a CAGR of 6.37% during the forecast period from 2024 to 2030 | DelveInsight

The Pediatric Neurology Devices market is estimated to grow at a CAGR of 6.37% during the forecast period from 2024 to 2030, driven by the rising prevalence of pediatric neurological disorders and growing demand for minimally invasive treatment options.

DelveInsight's Pediatric Neurology Devices Market Insights Report 2030 provides current and forecast market analysis, individual leading Pediatric Neurology Devices companies' market shares, challenges, Pediatric Neurology Devices Market Drivers, barriers, trends, and key market Pediatric Neurology Devices companies in the market.

To read more about the latest highlights related to the Pediatric Neurology Devices Market @ https://www.delveinsight.com/sample-request/pediatric-neurology-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Pediatric Neurology Devices Market Report

* In October 2022, Axoft announced FDA Breakthrough Device designation for its brain-machine interface (BMI) designed to treat long-term neurological disorders, a minimally invasive device that tracks brain signals through an ultra-high density of sensors. Strategic significance: Advances next-generation brain-computer interface technology toward regulatory approval.
* In August 2022, Abbott received FDA approval for its Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy, offering pain coverage across up to six areas of the limbs. Strategic significance: Expands Abbott's neurostimulation portfolio for pain management applications.
* In 2023, Medtronic launched the Percept PC Deep Brain Stimulation (DBS) system with BrainSense technology, designed to capture brain signals while simultaneously delivering therapeutic stimulation inside and outside the clinic. Strategic significance: Strengthens Medtronic's DBS offering for Parkinson's disease, tremor, dystonia, and epilepsy patients.
* The principal drivers are the increasing prevalence of neurological disorders such as epilepsy, autism, Parkinson's disease, dystonia, and tremors in children; rising incidence of pediatric brain tumors; growing patient and physician preference for minimally invasive treatment; increasing government research funding; and rising product launches and regulatory approvals.
* The leading Pediatric Neurology Devices Companies include Medtronic, Abbott, Boston Scientific Corporation, LivaNova PLC, Natus Medical Incorporated, KARL STORZ SE & Co. KG, Zimmer Biomet, Stryker, Integra LifeSciences, B. Braun SE, NeuroSigma, Inc., Desco Medical India, Biçakcilar, Sophysa, Axoft Inc., and others.

To know more about why North America is leading the market growth in the Pediatric Neurology Devices Market, get a snapshot @ https://www.delveinsight.com/sample-request/pediatric-neurology-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Pediatric Neurology Devices Overview

Pediatric neurology devices are medical devices used for the treatment and management of neurological conditions in neonates, infants, children, and adolescents. Spanning neurosurgery devices, neurostimulation devices, and cerebrospinal fluid management devices, these technologies support the diagnosis and treatment of conditions such as brain tumors, epilepsy, autism spectrum disorder, and Parkinson's disease, helping clinicians manage complex neurological conditions in the pediatric population with increasingly minimally invasive approaches.

Pediatric Neurology Devices Market Key Growth Drivers

* The rising prevalence of neurological and developmental disorders among children is a core driver of demand. The World Health Organization reported that about one in 100 children had autism worldwide in 2023, often alongside co-occurring conditions such as epilepsy, depression, anxiety, and ADHD.
* Cerebral palsy adds further to the pediatric neurological disease burden. Cerebral Palsy Guidance data for 2023 indicate that nearly 500,000 children and teens live with cerebral palsy globally, with around 10,000 babies born with the condition each year.
* Pediatric brain and CNS tumors represent a significant clinical need in the United States. The American Cancer Society estimated more than 4,000 brain and spinal cord tumors are diagnosed annually in children and teens, while ASCO projected 5,230 new pediatric CNS tumor diagnoses in the U.S. for 2023.
* Autism spectrum disorder diagnoses continue to rise in the U.S., with the CDC reporting that approximately 1 in 36 children were diagnosed with ASD in 2020, and boys roughly four times more likely to be diagnosed than girls.
* Pediatric migraine is a widespread but often under-addressed condition. The American Migraine Foundation estimated that about 10% of U.S. children experienced migraine in 2019, supporting demand for devices such as gammaCore Sapphire, which received FDA approval in February 2021 for acute and preventive migraine treatment in adolescents aged 12 to 17.
* Growing preference for minimally invasive treatment is reshaping care pathways, as these devices offer reduced scarring, faster recovery, less post-operative pain, and shorter hospital stays compared with conventional surgery.
* Continued regulatory approvals and product launches, such as NeuroSigma's November 2022 launch of an external trigeminal nerve stimulation (eTNS) device for pediatric ADHD, are expanding the range of treatment options available to clinicians and families.

Get a sneak peek at the Pediatric Neurology Devices Market Dynamics @ https://www.delveinsight.com/sample-request/pediatric-neurology-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Pediatric Neurology Devices Market Segment Analysis

The Pediatric Neurology Devices market is segmented by Product (Neurosurgery Devices, Neurostimulation Devices, Cerebrospinal Fluid Management Devices, and Others), Application (Brain Tumor, Epilepsy, Autism Spectrum Disorder, Parkinson's, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product, the neurostimulation devices category is expected to command a significant revenue share in 2023, reflecting the clinical value of delivering targeted electrical stimulation to the brain, spinal cord, or peripheral nervous system for movement-related disorders such as Parkinson's disease and epilepsy. Continued product approvals, including neurostimulation devices designed for pediatric ADHD, are expected to further support segment growth through the forecast period.

Which MedTech key players in the Pediatric Neurology Devices Market are set to emerge as the trendsetter? Explore @ https://www.delveinsight.com/sample-request/pediatric-neurology-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Pediatric Neurology Devices Market Competitive Landscape

The Pediatric Neurology Devices market brings together large, diversified medical technology companies and focused neurology device specialists. Established players including Medtronic, Abbott, Boston Scientific Corporation, LivaNova PLC, Stryker, and Zimmer Biomet anchor the market through broad neurosurgery, neurostimulation, and CSF management portfolios alongside global commercial reach. Specialized players such as Natus Medical Incorporated, KARL STORZ SE & Co. KG, Integra LifeSciences, B. Braun SE, NeuroSigma, Inc., Desco Medical India, Biçakcilar, Sophysa, and Axoft Inc. compete through differentiated technologies, including emerging brain-machine interface platforms, supporting continued innovation across the pediatric neurology care pathway.

Pediatric Neurology Devices Companies

Medtronic, Abbott, Boston Scientific Corporation, LivaNova PLC, Natus Medical Incorporated, KARL STORZ SE & Co. KG, Zimmer Biomet, Stryker, Integra LifeSciences, B. Braun SE, NeuroSigma, Inc., Desco Medical India, Biçakcilar, Sophysa, Axoft Inc., and others.

Pediatric Neurology Devices Market Restraints

Despite steady momentum, the market faces certain constraints. Risks associated with various neurological devices, including procedural and device-related complications, can weigh on adoption, while the surging use of pharmacological treatments for neurological disease management presents an alternative to device-based approaches in some cases. The market also previously experienced a temporary setback during COVID-19, as lockdowns reduced patient visits to neurology and pediatric departments and disrupted manufacturing and supply chains, though demand has since recovered alongside the resumption of hospital and clinic visits.

Interested in knowing where the Pediatric Neurology Devices Market is heading by 2030? Click to get a snapshot of the Pediatric Neurology Devices Market Trends - https://www.delveinsight.com/sample-request/pediatric-neurology-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Pediatric Neurology Devices Market Report

* Coverage - Global
* Forecast Period - 2024-2030
* Pediatric Neurology Devices Companies - Medtronic, Abbott, Boston Scientific Corporation, LivaNova PLC, Natus Medical Incorporated, KARL STORZ SE & Co. KG, Zimmer Biomet, Stryker, Integra LifeSciences, B. Braun SE, NeuroSigma, Inc., Desco Medical India, Biçakcilar, Sophysa, Axoft Inc., and others
* Pediatric Neurology Devices Market Restraints and Regulatory Analysis
* Pediatric Neurology Devices Porter's Five Forces Analysis and Market Assessment

Explore more information on the Pediatric Neurology Devices Market Insights @ https://www.delveinsight.com/sample-request/pediatric-neurology-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Pediatric Neurology Devices Market Report Introduction
2. Pediatric Neurology Devices Market Executive Summary
3. Regulatory Analysis
4. Pediatric Neurology Devices Market Key Factors Analysis
5. Pediatric Neurology Devices Market Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Pediatric Neurology Devices Market
7. Pediatric Neurology Devices Market Layout
8. Pediatric Neurology Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.